INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

Studies from this and other laboratories have shown that herpes simplex virus 1 (HSV-1) infection of susceptible cells has a profound effect on the infected cell (28). More recent studies have focused on the effect of viral gene products on the proteins that regulate the cell cycle. The studies described in this report have as their genesis the observation that the HSV-1 promiscuous transactivator infected-cell protein 0 (ICP0) stabilizes cyclin D3 without affecting its interaction with cyclin-dependent kinase 4 (cdk4) or phosphorylation of retinoblastoma protein (pRb) (17). In later studies, it was shown that substitution of a single amino acid in ICP0 abrogates the binding and stabilization of cyclin D3 and reduces the neuroinvasiveness of the mutant from a peripheral site (38). The observation that other herpesviruses either bind the cyclin D appropriate for the cells in which they replicate (Epstein-Barr virus) or encode a functional D cyclin homolog (human herpesvirus 8 and herpesvirus saimiri) suggested that herpesviruses depend on the function of D cyclins for optimal replication and raised the possibility that this function involves activation of S-phase-related genes (19, 25, 33, 35, 36). One well-characterized function of cyclin D is to complex with cdk4 or cdk6 and to phosphorylate pRb (16, 21). In the process, pRb releases its grip on E2F. In turn, free E2F binds to cognate sites in promoters of genes expressed during S phase (5, 11, 14). A central question therefore is whether the stabilization of cyclin D3 in cells infected with wild-type HSV-1 causes an increase in the free E2F proteins measured by their binding to cognate DNA sites. This report deals with cells infected within a short time after synchronization and infection of quiescent human fibroblasts. We report that in these cells the levels of E2F capable of binding to cognate sites on its DNA remained similar to that of uninfected cells during the first 4 h after infection but was reduced at least sixfold between 4 and 8 h after infection in cycling and by 30% in quiescent cells. Of particular interest is the emergence in HSV-1-infected cells of E2F-1, E2F-2, E2F-4, and E2F-5 protein characterized by altered mobility in denaturing gels. Relevant to this report are the following findings.

(i) The E2F family of transcription factors is currently composed of six known members (E2F-1 to E2F-6). The E2F family members can be classified into two groups. E2F-1, -2, and -3 accumulate in a cell cycle-dependent manner, have a nuclear localization signal, and induce S-phase progression (24, 39). E2F-4 and -5 levels are relatively constant throughout the cell cycle, their subcellular localization is dependent on associated proteins, and they are poor inducers of S phase. All family members form heterodimers with DP1 or DP2 (reviewed in references 2 and 11). The transcriptional activity of E2F is repressed when complexed to pRb pocket proteins (10). The transition from G₁ to S phase involves sequential activation of cyclin D-cdk4 and cyclin E-cdk2 kinase complexes (22). Both cyclin D-cdk4 and cyclin E-cdk2 phosphorylate pRb to release E2F and initiate the transcription of E2F-dependent genes.

(ii) E2F-1, the most thoroughly characterized member of the E2F family, is capable of activating transcription of a variety of genes involved in cellular DNA synthesis (DNA polymerase -dihydrofolate reductase and ribonucleotide reductase) and cell cycle progression (cdk2 and cyclin A) (5, 11). E2F-1 can function as both an oncogene and a tumor suppressor. An apparently contradictory function of E2F-1 is its role in promoting apoptosis (9, 42). The induction of apoptosis by E2F-1 is in part mediated by its ability to bind DNA.

(iii) At least three families of DNA viruses have been reported to encode viral proteins that accelerate the onset of S phase in the infected cell by targeting the release of E2F from pRb (6, 7). Thus, the adenovirus E1a, the papillomavirus E7, and simian virus-40 T antigen have been reported to disrupt pRb-E2F complexes (4, 6, 40).

In addition to the studies reported above (17, 38) recently several laboratories have reported on the effects of HSV-1 infection on cellular proteins involved in cell cycle regulation. (i) Replication of HSV-1 is reduced in cells following the addition of high concentrations of inhibitors of cdk2, cdc2, and cdk5 (15, 30-32). (ii) HSV-1 causes the activation of the G₂/M kinase cdc2 even though cyclin A and B levels are reduced (1). (iii) Overexpression of ICP0 results in cell cycle arrest at the G₁ and G₂/M phases (13, 20). (iv) HSV-1 infection results in a block in S-phase progression and hypoactivated cdk2 (3, 7). (v) A fraction of pRb in HSV-1 infected cells is alternatively phosphorylated (30). (vi) pRb and p53 have been reported to localize to sites of viral DNA replication in HSV-1-infected cells (41). (vii) HSV-1 induces in infected cells free and heteromeric forms of E2F as measured by gel shift assays (12). (vii) E2F-4 is translocated from the cytoplasm into the nucleus following infection, which is reminiscent of the G₀ phase of the cycle (26).

Since some viruses target pRb and cytomegalovirus phosphorylates E2F proteins (23, 27), the objective of this study was to characterize the effect of HSV-1 infection on E2F and the ability of HSV-1-modified E2F to bind to DNA.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Cells and viruses. HeLa and HEp-2 were initially obtained from the American Type Culture Collection and maintained in Dulbecco modified Eagle medium with 10% newborn calf serum. Human embryonic lung (HEL) fibroblasts were obtained from Aviron (Mountain View, Calif.) and maintained in 5% newborn calf serum. HSV-1(F) is the prototype wild-type HSV-1 strain used in our laboratory (8).

Cell infection. Confluent 150-cm² flasks of HeLa or HEp-2 cells were harvested and plated on 25-cm² flasks. Cells were allowed to adhere for 1 h, after which unattached cells were aspirated. The attached cells were then exposed 2 × 10⁷ PFU of HSV-1(F) in 1 ml of 199V (medium 199 supplemented with 1% calf serum) and placed on a rotary shaker at 37°C. After 2 h, the inoculum was replaced with 5 ml of fresh Dulbecco modified Eagle medium supplemented with 10% newborn calf serum, and the culture were incubated at 37°C until the cells were harvested. Flasks (150 cm²) of HEL fibroblasts were grown to confluence and held at confluence for 1 week to achieve contact-inhibited and serum-starved conditions. Quiescent HEL fibroblasts were infected as follows. Spent medium was aspirated from the flasks and saved; 2 × 10⁸ PFU of HSV-1(F) was added to 6 ml of spent medium and overlaid on the cells. Mock-infected cells were treated by the addition of a similar volume of milk buffer into the spent medium. Infection proceeded for 2 h at 37°C on a rotary shaker, after which the inoculum was replaced with 25 ml of spent medium.

Cytoplasmic and nuclear fractionation. Cells were harvested at various time points as follows. The medium was removed; the cells were rinsed in phosphate-buffered saline (PBS), scraped into 5 ml of PBS, and pelleted by centrifugation. The cell pellet was gently resuspended in hypotonic lysis buffer (10 mM HEPES [pH 7.5], 10 mM KCl, 3 mM MgCl₂, 0.05% NP-40, 1 mM EDTA, 10 mM NaF, 10 mM -glycerophosphate, 1 mM dithiothreitol [DTT], 0.1 mM sodium orthovanadate, 0.5 mM phenylmethylsulfonyl fluoride) by gently pipetting up and down 10 times and kept on ice for 30 min. The lysate was pelleted at 2,500 rpm (500 × g) for 5 min at 4°C. The cytoplasmic fraction (supernatant) was transferred to a new tube. The pelleted nuclei were gently washed in hypotonic lysis buffer and pelleted as above. The nuclei were lysed by resuspending the pellet in high-salt lysis buffer (50 mM HEPES [pH 7.9], 250 mM KCl, 0.1% NP-40, 0.1 mM EDTA, 10 mM NaF, 10 mM -glycerophosphate, 1 mM DTT, 0.1 mM sodium orthovanadate, 0.5 mM phenylmethylsulfonyl fluoride, 5% glycerol) and stored on ice for 30 min. The lysate was spun down at 14,000 rpm for 10 min at 4°C. Protein concentrations of the nuclear and cytoplasmic fraction were determined using the Bradford assay (Bio-Rad). Protein concentrations were then equalized between mock- and HSV-1(F)-infected cells.

E2F oligonucleotide labeling. E2F consensus DNA binding oligonucleotide was purchased from Santa Cruz Biotechnology (sc-2507). Alternatively, oligonucleotides were synthesized to the E2 promoter sequence and dihydrofolate reductase promoter sequence corresponding to E2F binding sites. The oligonucleotide was end labeled with ³²P as follows. Three picomoles of oligonucleotide, 150 µCi of [-³²P]ATP, 15 U of bacteriophage T4 polynucleotide kinase, and bacteriophage T4 polynucleotide kinase buffer were reacted in 20 µl (total volume) at 37°C for 45 min. The T4 polynucleotide kinase was inactivated by heating the reaction mixture at 68°C for 10 min. Labeled oligonucleotide was separated from free [-³²P]ATP by Sephadex G-50 spin column chromatography and stored at 20°C.

E2F electrophoretic mobility shift and supershift assays. The binding reaction mixture contained 0.5 to 10 µg of protein, 3 µg of poly(dI-dC), 0.5 ng of ³²P-labeled E2F consensus sequence oligonucleotide, binding buffer (5× = 100 mM HEPES [pH 7.9], 200 mM KCl, 30 mM MgCl₂, 5 mM DTT, 25% glycerol, 0.5% NP-40, 5 mM EDTA). The binding reaction was brought up to a total volume of 20 to 30 µl. Binding reactions mixtures with unlabeled cold excess of E2F oligonucleotide consensus binding sequence had 50 ng (100-fold excess) of unlabeled E2F consensus sequence oligonucleotide. Binding reactions were carried out for 20 min at room temperature. Samples were then loaded onto 4% nondenaturing polyacrylamide gels and subjected to electrophoresis in Tris-borate-EDTA buffer for 75 min at 180 V. Gels were dried and analyzed by a PhosphorImager (Storm 860; Molecular Dynamics) and autoradiography.

Immunoblotting. Cytoplasmic and nuclear fractions were denatured by boiling in disruption buffer (final concentration of 2% sodium dodecyl sulfate [SDS], 50 mM Tris [pH 7.2], 2.75% sucrose, 5% -mercaptoethanol, and bromophenol blue) was added to equivalent amounts of protein from samples. The extracts were boiled for 5 min, subjected to electrophoresis on 8 or 10% bisacrylamide gels, transferred to nitrocellulose membranes, blocked for 2 h with 5% nonfat dry milk, and reacted with the appropriate antibody. Antibodies against E2F-1, E2F-2, E2F-3, E2F-4, and E2F-5 (Santa Cruz) were diluted 1:200 in PBS with 0.05% Tween 20 and 1% bovine serum albumin and reacted for 2 h at room temperature. The immunoblots were exposed to the secondary antibodies diluted 1:3,000 (alkaline phosphatase [AP] conjugated [Bio-Rad] or peroxidase conjugated [Sigma]) for 1 h. To develop AP-conjugated secondary antibodies, the immunoblots were reacted with AP buffer (100 mM Tris [pH 9.5], 100 mM NaCl, 5 mM MgCl₂), followed by AP buffer containing 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium. The reaction was stopped by the addition of Tris (pH 7.6) and 10 mM EDTA. Peroxidase-conjugated secondary antibodies were developed by enhanced chemiluminescence according to instructions supplied by the manufacturer (Pierce). All rinses were done in PBS containing 0.05% Tween 20.

AP treatment. Nuclear and cytoplasmic fractions of cells were harvested as above except that lysis was done with or without the addition of phosphatase inhibitors (NaF, -glycerophosphate, and sodium orthovanadate) to the hypotonic and high-salt lysis buffers. Equivalent amounts of protein from samples were reacted with 5 U of calf intestine alkaline phosphatase (CIAP) and appropriate reaction buffer for 30 min at 34°C. Reactions were stopped by the addition of gel loading buffer. Samples were assayed by immunoblotting as described above.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

HSV-1 infection results in the accumulation of novel isoforms of E2F-1 in cycling cells and accumulation of a high-molecular-weight isoform in quiescent cells. Infected or mock-infected HEp2 or HeLa cells were fractionated into nuclear and cytoplasmic extracts. The lysates were subjected to electrophoresis in a denaturing gel, transferred to a nitrocellulose sheet, and reacted with antibodies to E2F-1. E2F-1, a predominantly nuclear protein, was found almost exclusively in the nuclear fraction of uninfected HeLa or HEp2 cells (Fig. 1). The results show that at 4 h after infection, nuclear extracts of infected HeLa cells formed two prominent E2F-1 bands that could not be differentiated from those of mock-infected cells. An additional E2F-1 band migrating between the two prominent bands was formed by lysates of HeLa cells harvested at 8 or 16 h after infection. This E2F-1 band specific for HSV-1-infected cells was formed by lysates of HEp-2 cells harvested as early as 4 h after infection (Fig. 1). While the cytoplasmic fractions of mock-infected HeLa or HEp2 cells harvested at 4, 8, or 16 h after infection contained only trace amounts of E2F-1, the cytoplasmic fraction of cells harvested at 8 and 16 h (HeLa) or 16 h (HEp-2) after infection each formed a single prominent E2F-1 band (Fig. 1). The electrophoretic mobility of this band was slower that of bands formed by nuclear extracts of mock-infected or infected cells.

View larger version (27K): [in this window] [in a new window]   FIG. 1.   Immunoblot of cytoplasmic (Cyto.) and nuclear (Nuc.) fractions of uninfected or HSV-1(F)-infected HeLa and HEp-2 cell lysates separated on bisacrylamide gels and reacted with antibody to E2F-1 as described in Materials and Methods. The cells were infected at time zero and harvested at the indicated times after infection.

View larger version (44K): [in this window] [in a new window]   FIG. 2.   Immunoblot of cytoplasmic and nuclear fractions of uninfected or HSV-1(F)-infected serum-starved, contact-inhibited HEL fibroblasts lysates separated on bisacrylamide gels and reacted with antibody to E2F-1. Cells were infected at time zero and harvested at the indicated times after infection.

E2F-2 accumulates in decreased amounts in infected cells. The results of an experiment similar to those reported above indicated that the quantity and electrophoretic mobility of E2F-2 accumulating in cells during the first 8 h after infection could not be differentiated from that of mock-infected cells in cycling HEp-2 cells (Fig. 3). At 16 h after infection, there was a decrease in the accumulation of nuclear E2F-2 (Fig. 3). In HEL fibroblasts, nuclear E2F-2 migrated as a doublet (Fig. 4). In mock-infected cells, there was an equivalent amount of each isoform of E2F-2, whereas HEL fibroblasts accumulated predominantly the upper form of E2F-2 at 8 and 12 h after infection. A small but equal proportion of E2F-2 was found in the cytoplasm of mock-infected or HSV-1-infected cells between 4 and 12 h after infection (data not shown).

View larger version (46K): [in this window] [in a new window]   FIG. 3.   Immunoblot of nuclear fractions of uninfected or HSV-1(F)-infected HEp-2 cell lysates separated on bisacrylamide gels and reacted with antibody to E2F-2. Cells were infected at time zero and harvested at the indicated times after infection.

View larger version (44K): [in this window] [in a new window]   FIG. 4.   Immunoblot of nuclear fractions of uninfected or HSV-1(F)-infected serum-starved, contact-inhibited HEL fibroblasts lysates separated on bisacrylamide gels and reacted with antibody to E2F-2. Cells were infected at time zero and harvested at the indicated times after infection.

HSV-1 causes posttranslational modification of E2F-4. It was reported earlier (26) that E2F-4 was modified and translocated to the nucleus of HSV-1-infected cells. Our studies of E2F-4 yielded the following results. (i) In noninfected HEp-2 cells, E2F-4 localized in both the cytoplasmic and nuclear fractions and formed one major band and several fainter, both faster- and slower-migrating bands (Fig. 5, lanes 1, 5, 9, and 13). In HSV-1-infected cells, E2F-4 present in both cytoplasmic and nuclear fractions formed a large number of bands that tended to increase in M_r range from 55,000 to 76,000 with time after infection (lanes 3, 7, 11, and 15). The high-apparent-molecular-weight bands were particularly prominent in electrophoretic profiles of nuclear fractions of infected cells (lanes 7 and 15).

View larger version (69K): [in this window] [in a new window]   FIG. 5.   Immunoblot of cytoplasmic and nuclear fractions of uninfected or HSV-1(F)-infected HEp-2 cell lysates treated with or without CIAP, separated on bisacrylamide gels, and reacted with antibody to E2F-4. Cells were infected at time zero and harvested at the indicated times after infection. The boxed region indicates the isoforms of E2F-4 detected.

View larger version (42K): [in this window] [in a new window]   FIG. 6.   Immunoblot of cytoplasmic and nuclear fractions of uninfected or HSV-1(F)-infected serum-starved, contact-inhibited HEL fibroblasts lysates separated on bisacrylamide gels and reacted with antibody to E2F-4. Cells were infected at time zero and harvested at the indicated times after infection. Multiple E2F-4-reactive bands were observed as indicated by the vertical lines.

HSV-1 effects on E2F-5. E2F-5 present in mock-infected HEp-2 cells revealed two prominent bands (Fig. 7, lane 1). E2F-5 in lysates of cells harvested at 14 h after infection with HSV-1 accumulated in addition a third isoforms whose electrophoretic mobility was intermediate between those of the two isoforms present in mock-infected cells (lanes 1 and 2).

View larger version (31K): [in this window] [in a new window]   FIG. 7.   Immunoblot of nuclear fractions of uninfected or HSV-1(F)-infected HEp-2 cell lysates separated on bisacrylamide gels and reacted with antibody to E2F-5. Cells were infected at time zero and harvested at 14 h after infection.

View larger version (40K): [in this window] [in a new window]   FIG. 8.   Immunoblot of cytoplasmic and nuclear fractions of uninfected or HSV-1(F)-infected serum-starved, contact-inhibited HEL fibroblasts lysates separated on bisacrylamide gels and reacted with antibody to E2F-5. Cells were infected at time zero and harvested at the indicated times after infection.

AP treatment of E2F-1 and E2F-4 accumulating in HSV-1-infected cells. E2F proteins are known to be regulated by phosphorylation. Multiple bands of E2F-1 have been observed by immunoblotting, and these coalesce into a single band following phosphatase treatment of the cell extract (43). E2F-4 has a hyperphosphorylated form that that also migrates faster in denaturing gels after phosphatase treatment (37). The phosphorylated form of E2F-4 is thought to act as a transcriptional repressor. The transition to G₁ and S results in a dephosphorylated form that can no longer act as a transcriptional repressor. To determine if HSV-1 infection resulted in the preferential accumulation of specific phosphorylated forms of E2F-1 and E2F-4, two sets of experiments were done.

View larger version (50K): [in this window] [in a new window]   FIG. 9.   Immunoblot of nuclear fractions of uninfected or HSV-1(F)-infected HEp-2 cell lysates treated with or without CIAP, separated on bisacrylamide gels, and reacted with antibody to E2F-1. Cells were infected at time zero and harvested at the indicated times after infection.

E2F proteins accumulating in nuclei of infected cells cease to bind to cognate sites on DNA. To determine the state of E2F DNA binding activity in HSV-1-infected cells, electrophoretic mobility shift assays were done with labeled DNA fragments containing the E2F consensus binding site and nuclear or cytoplasmic extracts of mock-infected or HSV-1(F)-infected HeLa cells. The results (Fig. 10) were as follows.

View larger version (74K): [in this window] [in a new window]   FIG. 10.   E2F DNA electrophoretic mobility shift assay of cytoplasmic and nuclear fractions of uninfected or HSV-1-infected HeLa cell lysates. Cells were infected at time zero and harvested at the indicated times. Increasing amounts of protein extract (0.5, 1, 5, and 10 µg) were reacted with 32P-end-labeled DNA with the E2F consensus binding site. To determine if the gel shift bands were competable, 100-fold excess unlabeled probe was added to 10 mg of each extract (lanes 5, 10, 15, and 20). Bands that were competable are labeled with a dark line.

Identification of the member of the E2F family bound to cognate DNA sequences. In this series of experiments, mixtures of HEp-2 cell extracts and DNA oligonucleotides containing an E2F binding site described above were reacted with antibody to either E2F-1, E2F-2, E2F-3, or E2F4 and then subjected to electrophoresis on nondenaturing gels as described in Materials and Methods. The results (Fig. 11) were as follows.

View larger version (70K): [in this window] [in a new window]   FIG. 11.   E2F DNA electrophoretic mobility shift and supershift assays of nuclear fractions of uninfected or HSV-1(F)-infected HEp-2 cell lysates. Cells were infected at time zero and harvested at indicated times; 5 µg of protein extract was subjected to gel shift assay without antibody (Ab.; lanes 1 and 2). Supershift assays were done with the indicated antibodies as described in Materials and Methods (lanes 3 to 10).

E2F-2 is also the predominant E2F family member in HEL fibroblasts. Experiments similar to those described above were also done with extracts of mock-infected or infected quiescent, contact-inhibited HEL fibroblasts. In this instance, the DNA-protein complexes were fainter but more numerous. To identify specific protein-DNA complexes, excess unlabeled DNA was added to mixtures containing probe and extracts from cells harvested at 4 h after mock infection and mixtures containing extracts of cells infected for 12 h after infection. The results were as follows.

View larger version (59K): [in this window] [in a new window]   FIG. 12.   E2F DNA electrophoretic mobility shift assays of cytoplasmic (A) and nuclear (B) fractions of uninfected or HSV-1(F)-infected serum-starved, contact-inhibited HEL fibroblasts lysates. Cells were infected at time zero and harvested at indicated times; 5 µg of protein extract was subjected to gel shift assay. Circles are next to bands specific to either uninfected or HSV-1(F)-infected lysates. Competable gel shift bands were determined by the addition of 100-fold excess unlabeled DNA probe (lanes 5, 6, 12, and 13). Labeled probe without protein extract was loaded in lanes 7 and 14. (C) E2F DNA electrophoretic mobility supershift assays with nuclear lysate of uninfected HEL fibroblast lysates. The square shows the shift upward of a E2F-2-DNA complex.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

The consensus of the studies carried out in several laboratories and detailed in the introduction is that HSV selectively modifies cell cycle proteins and that in the instances in which this has been critically examined, the modifications are dependent on the presence of specific viral gene products. The studies described in this report are a sequel of studies initiated several years ago and are based on the observation that ICP0 binds and stabilizes cyclin D3 (17). In principle, cyclin D3-cdk4 complex together with the downstream cyclin E-cdk2 should phosphorylate pRB, release the bound members of the E2F family, and activate the S phase of the DNA cycle. At least at times in the viral replicative cycle tested, this does not appear to be the case. Thus, in the mid or late times during the viral replicative cycle, pRB is hypophosphorylated and cdk2 is not activated (7, 34). Consistent with the logical inferences arising from these results, other studies have shown that HSV-1 infection results in the accumulation of heteromeric forms of E2F that in part contain pRb (12). Also, E2F-4 had been shown to accumulate in the nucleus as a hyperphosphorylated form (26). While these studies would suggest that E2F proteins are not released, it has been also shown that E1a and E7 proteins of adenovirus and human papillomavirus, respectively, bind pRB directly and cause the release of E2F (6, 40). Also, a cytomegalovirus-encoded kinase has been shown to directly phosphorylate E2F molecules (27). The studies described in this report focused on the status of the members of the E2F family both in cycling (HEp-2 and HeLa) cells and in quiescent HEL fibroblasts. Our results may be summarized as follows:

(i) E2F-1 was found predominantly in nuclei of mock-infected HeLa or HEp-2 cells. In infected cells, E2F-1 was in part translocated into the cytoplasm, and both the nuclear and cytoplasmic E2F-1 acquired a slower electrophoretic mobility in denaturing polyacrylamide gels. E2F-5 was present solely in the nuclei of infected or mock-infected cells. In this instance, least a fraction of the protein was modified with respect to electrophoretic mobility. For E2F-4, novel hyperphosphorylated forms were found in both the cytoplasmic and nuclear fractions of infected cells. E2F-2 detected in mock-infected cells could not be differentiated with respect to amounts of electrophoretic mobility from those detected in cells harvested until at least 12 h after infection. At 16 h after infection, there was a decrease in the amounts of detectable E2F-2.

(ii) The studies on infected quiescent, contact-inhibited HEL fibroblasts revealed that members of E2F family were subjected to posttranslational processing or translocation even in the absence of cell cycle progression. The majority of modifications in E2F molecules occurred by 8 h after infection. Thus, a high-molecular-weight E2F-1 species accumulated in the nuclear and cytoplasmic fraction of HEL fibroblasts by 8 h after HSV-1 infection. E2F-2 present in the nuclear fraction also preferentially migrated as a higher-molecular-weight species. E2F-4 forms rearranged from the three predominant forms in uninfected cells to a high-molecular-weight form that was phosphorylated in both the nuclear and cytoplasmic fractions. Whereas the electrophoretic mobility of E2F-5 remained unaltered, the protein was at least in part translocated into the cytoplasm.

(iii) In G₁/S synchronized cycling cells, E2F DNA binding ability increased with time in mock-infected cells. Concurrent with posttranslational modifications described above, we observed a decrease in the affinity of E2F contained in infected cells for cognate DNA sites. Curiously, DNA probe-protein complex formed at least two (Fig. 10) and in some instances three (Fig. 11) bands differing in electrophoretic mobility. All of the bands decreased in amount with time after infection. However, only the antibody to E2F-2 reacted with the proteins contained in these complexes, and in this instance the antibody supershifted the entire DNA-protein complex, indicating that the protein in that complex contained predominantly the E2F-2 member of the E2F family. The possibility that in cultured cells E2F-2 is the predominant E2F species was also suggested by the observation that mock-infected HEL fibroblasts also contained E2F-2 which formed a distinct DNA-protein band (Fig. 12).

The significance of the studies described in this report stem from the following considerations.

(i) Cyclins and cdks are in part responsible for preparing the cellular environment for particular phases of the cell cycle. The G₁/S transition is mediated by the sequential activation of cdk4/6 with D-type cyclins followed by cdk2/cyclin E (22). The studies involving the use of cdk inhibitors suggest that they play a crucial role in the transcription of genes early in infection. The stabilization of cyclin D3 by ICP0 is also an early event inasmuch as cyclin D3 persists only 6 to at most 10 h after infection (17, 38).

(ii) The conclusion based on the accumulation of cyclin D3 and its partner, cdk4, and the effects of cdk inhibitors that at least some aspects of S-phase genes are activated and play a role in viral replication is marred by the observation reported elsewhere that cdk2, is not activated and that the status of pRB is inconsistent with activation of the S phase (30). In this study we show that E2F proteins either are extensively modified, are translocated to the cytoplasmic compartment, or become inactive with respect to binding to cognate DNA sites.

(iii) From our knowledge of the events occurring in the course of the viral replicative cycle, the key events that could require the involvement of G₀/S-phase cyclins are early transcription of viral gene and viral DNA synthesis. Studies done many years ago indicate that viral DNA synthesis is initiated sometime around 3 h after infection (29). The changes in cell cycle proteins described to date appear to occur in most instances after 4 h after infection. In some instances they are delayed to as long as 12 h after infection.

The fundamental conclusion that must be reached from the studies published to date is that the functions necessary to activate S-phase genes are inoperative at late stages of infection, i.e., at 8 h after infection or later in either cycling or quiescent cells. More specifically, studies done to date do not rule a transient induction of S-phase genes early in infection.

The curious issue that must also be addressed is the events taking place in quiescent, contact-inhibited HEL fibroblasts. The observation that several members of the E2F family were modified or translocated to nonfunctional sites even though the cells were not in S phase at the time of infection is at odds with the hypothesis that the virus evolved functions to block the expression of S-phase genes. The obvious question is why are E2F proteins modified late in infection of quiescent cells. One hypothesis is that E2F proteins transiently performed their natural roles and were then shut off. An alternative hypothesis is that HSV encodes functions that modify members of the E2F family irrespective of the status of the cell cycle. Analyses now in progress on the transcripts of cellular genes made in cells early in infection may ultimately yield the answer to this question.